Abstract:Background Src plays various roles in tumour progression, invasion, metastasis, angiogenesis and survival. It is one of the multiple targets of multi-target kinase inhibitors in clinical uses and trials for the treatment of leukemia and other cancers. These successes and appearances of drug resistance in some patients have raised significant interest and efforts in discovering new Src inhibitors. Various in-silico methods have been used in some of these efforts. It is desirable to explore additional in-silico methods, particularly those capable of searching large compound libraries at high yields and reduced false-hit rates. Results We evaluated support vector machines (SVM) as virtual screening tools for searching Src inhibitors from large compound libraries. SVM trained and tested by 1,703 inhibitors and 63,318 putative non-inhibitors correctly identified 93.53%~ 95.01% inhibitors and 99.81%~ 99.90% non-inhibitors in 5-fold cross validation studies. SVM trained by 1,703 inhibitors reported before 2011 and 63,318 putative non-inhibitors correctly identified 70.45% of the 44 inhibitors reported since 2011, and predicted as inhibitors 44,843 (0.33%) of 13.56M PubChem, 1,496 (0.89%) of 168 K MDDR, and 719 (7.73%) of 9,305 MDDR compounds similar to the known inhibitors. Conclusions SVM showed comparable yield and reduced false hit rates in searching large compound libraries compared to the similarity-based and other machine-learning VS methods developed from the same set of training compounds and molecular descriptors. We tested three virtual hits of the same novel scaffold from in-house chemical libraries not reported as Src inhibitor, one of which showed moderate activity. SVM may be potentially explored for searching Src inhibitors from large compound libraries at low false-hit rates.

Classification of Src Kinase Inhibitors Based on Support Vector Machine

A novel tree kernel support vector machine classifier for modeling the relationship between bioactivity and molecular descriptors

Development and Experimental Test of Support Vector Machines Virtual Screening Method for Searching Src Inhibitors from Large Compound Libraries.

QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.

In Silico Prediction of Spleen Tyrosine Kinase Inhibitors Using Machine Learning Approaches and an Optimized Molecular Descriptor Subset Generated by Recursive Feature Elimination Method.

Enhanced Replacement Method‐based Quantitative Structure–Activity Relationship Modeling and Support Vector Machine Classification of 4‐anilino‐3‐quinolinecarbonitriles As Src Kinase Inhibitors

Predicting Anti‐HIV‐1 Activities of HEPT‐analog Compounds by Using Support Vector Classification

Virtual Screening of Selective Multitarget Kinase Inhibitors by Combinatorial Support Vector Machines

QSAR Studies on 4-Anilino-3-quinolinecarbonitriles As Src Kinase Inhibitors Using Robust PCA and Both Linear and Nonlinear Models

Classification models and SAR analysis of anaplastic lymphoma kinase (ALK) inhibitors using machine learning algorithms with two data division methods

A two-step target binding and selectivity support vector machines approach for virtual screening of dopamine receptor subtype-selective ligands.

Application of Support Vector Machine Classification Model to Identification of Vascular Endothelial Growth Factor Receptor Inhibitors

Classification of G-protein Coupled Receptors Based on Support Vector Machine with Maximum Relevance Minimum Redundancy and Genetic Algorithm

Effect of molecular descriptor feature selection in support vector machine classification of pharmacokinetic and toxicological properties of chemical agents.

Structure-Activity Relationship Study of Oxindole-Based Inhibitors of Cyclin-Dependent Kinases Based on Least-Squares Support Vector Machines

Virtual Screening of Abl Inhibitors from Large Compound Libraries by Support Vector Machines.

Classification Models for Herg Potassium Channel Inhibitors Based on the Support Vector Machine Approach

Classification of 5-Ht1a Receptor Ligands on the Basis of Their Binding Affinities by Using Pso-Adaboost-Svm

A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor

Evaluation of Virtual Screening Performance of Support Vector Machines Trained by Sparsely Distributed Active Compounds

Prediction of bioactivities of microsomal prostaglandin E2 synthase-1 inhibitors by machine learning algorithms